Synopsis
0
EU WC
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - 160MG/100ML
USFDA APPLICATION NUMBER - 18132
DOSAGE - INJECTABLE;INJECTION - 40MG/ML
USFDA APPLICATION NUMBER - 18132
DOSAGE - INJECTABLE;INJECTION - 80MG/100ML
USFDA APPLICATION NUMBER - 18132
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Controlled & Modified Release
Fillers, Diluents & Binders
Coating Systems & Additives
Topical
Thickeners and Stabilizers
Taste Masking
Film Formers & Plasticizers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Regulatory FDF Prices
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Annual Reports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
10 Feb 2025
Reply
17 Oct 2024
Reply
01 Oct 2024
Reply
02 Aug 2024
Reply
17 Jul 2021
Reply
20 Mar 2021
Reply
23 Jan 2021
Reply
02 Dec 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FDF DOSSIERS
Reply
15 Nov 2022
Reply
13 Feb 2021
Reply
13 Apr 2020
Reply
06 Jan 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
72
PharmaCompass offers a list of Dopamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dopamine manufacturer or Dopamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dopamine manufacturer or Dopamine supplier.
PharmaCompass also assists you with knowing the Dopamine API Price utilized in the formulation of products. Dopamine API Price is not always fixed or binding as the Dopamine Price is obtained through a variety of data sources. The Dopamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dopamine hydrochloride in dextrose 5% in plastic container manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dopamine hydrochloride in dextrose 5% in plastic container, including repackagers and relabelers. The FDA regulates Dopamine hydrochloride in dextrose 5% in plastic container manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dopamine hydrochloride in dextrose 5% in plastic container API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dopamine hydrochloride in dextrose 5% in plastic container manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dopamine hydrochloride in dextrose 5% in plastic container supplier is an individual or a company that provides Dopamine hydrochloride in dextrose 5% in plastic container active pharmaceutical ingredient (API) or Dopamine hydrochloride in dextrose 5% in plastic container finished formulations upon request. The Dopamine hydrochloride in dextrose 5% in plastic container suppliers may include Dopamine hydrochloride in dextrose 5% in plastic container API manufacturers, exporters, distributors and traders.
click here to find a list of Dopamine hydrochloride in dextrose 5% in plastic container suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dopamine hydrochloride in dextrose 5% in plastic container DMF (Drug Master File) is a document detailing the whole manufacturing process of Dopamine hydrochloride in dextrose 5% in plastic container active pharmaceutical ingredient (API) in detail. Different forms of Dopamine hydrochloride in dextrose 5% in plastic container DMFs exist exist since differing nations have different regulations, such as Dopamine hydrochloride in dextrose 5% in plastic container USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dopamine hydrochloride in dextrose 5% in plastic container DMF submitted to regulatory agencies in the US is known as a USDMF. Dopamine hydrochloride in dextrose 5% in plastic container USDMF includes data on Dopamine hydrochloride in dextrose 5% in plastic container's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dopamine hydrochloride in dextrose 5% in plastic container USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dopamine hydrochloride in dextrose 5% in plastic container suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Dopamine hydrochloride in dextrose 5% in plastic container Drug Master File in Japan (Dopamine hydrochloride in dextrose 5% in plastic container JDMF) empowers Dopamine hydrochloride in dextrose 5% in plastic container API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Dopamine hydrochloride in dextrose 5% in plastic container JDMF during the approval evaluation for pharmaceutical products. At the time of Dopamine hydrochloride in dextrose 5% in plastic container JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Dopamine hydrochloride in dextrose 5% in plastic container suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Dopamine hydrochloride in dextrose 5% in plastic container Drug Master File in Korea (Dopamine hydrochloride in dextrose 5% in plastic container KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Dopamine hydrochloride in dextrose 5% in plastic container. The MFDS reviews the Dopamine hydrochloride in dextrose 5% in plastic container KDMF as part of the drug registration process and uses the information provided in the Dopamine hydrochloride in dextrose 5% in plastic container KDMF to evaluate the safety and efficacy of the drug.
After submitting a Dopamine hydrochloride in dextrose 5% in plastic container KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Dopamine hydrochloride in dextrose 5% in plastic container API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Dopamine hydrochloride in dextrose 5% in plastic container suppliers with KDMF on PharmaCompass.
A Dopamine hydrochloride in dextrose 5% in plastic container CEP of the European Pharmacopoeia monograph is often referred to as a Dopamine hydrochloride in dextrose 5% in plastic container Certificate of Suitability (COS). The purpose of a Dopamine hydrochloride in dextrose 5% in plastic container CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Dopamine hydrochloride in dextrose 5% in plastic container EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Dopamine hydrochloride in dextrose 5% in plastic container to their clients by showing that a Dopamine hydrochloride in dextrose 5% in plastic container CEP has been issued for it. The manufacturer submits a Dopamine hydrochloride in dextrose 5% in plastic container CEP (COS) as part of the market authorization procedure, and it takes on the role of a Dopamine hydrochloride in dextrose 5% in plastic container CEP holder for the record. Additionally, the data presented in the Dopamine hydrochloride in dextrose 5% in plastic container CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Dopamine hydrochloride in dextrose 5% in plastic container DMF.
A Dopamine hydrochloride in dextrose 5% in plastic container CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Dopamine hydrochloride in dextrose 5% in plastic container CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Dopamine hydrochloride in dextrose 5% in plastic container suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dopamine hydrochloride in dextrose 5% in plastic container as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dopamine hydrochloride in dextrose 5% in plastic container API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dopamine hydrochloride in dextrose 5% in plastic container as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dopamine hydrochloride in dextrose 5% in plastic container and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dopamine hydrochloride in dextrose 5% in plastic container NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dopamine hydrochloride in dextrose 5% in plastic container suppliers with NDC on PharmaCompass.
Dopamine hydrochloride in dextrose 5% in plastic container Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dopamine hydrochloride in dextrose 5% in plastic container GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dopamine hydrochloride in dextrose 5% in plastic container GMP manufacturer or Dopamine hydrochloride in dextrose 5% in plastic container GMP API supplier for your needs.
A Dopamine hydrochloride in dextrose 5% in plastic container CoA (Certificate of Analysis) is a formal document that attests to Dopamine hydrochloride in dextrose 5% in plastic container's compliance with Dopamine hydrochloride in dextrose 5% in plastic container specifications and serves as a tool for batch-level quality control.
Dopamine hydrochloride in dextrose 5% in plastic container CoA mostly includes findings from lab analyses of a specific batch. For each Dopamine hydrochloride in dextrose 5% in plastic container CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dopamine hydrochloride in dextrose 5% in plastic container may be tested according to a variety of international standards, such as European Pharmacopoeia (Dopamine hydrochloride in dextrose 5% in plastic container EP), Dopamine hydrochloride in dextrose 5% in plastic container JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dopamine hydrochloride in dextrose 5% in plastic container USP).
Comment (4)
